JUTA PHARMA GMBH — Ras Importer Profile
Pharmaceutical Importer · #7 buyer for Ras · $3.6M import value · 141 shipments · GERMANY · DGFT Verified
JUTA PHARMA GMBH is the #7 importer of Ras from India with $3.6M in import value and 141 verified shipments. JUTA PHARMA GMBH holds a 2.3% market share in Ras imports based in GERMANY. The company sources from 1 verified supplier across 97 formulations shipped to 1 country.
JUTA PHARMA GMBH — Ras Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Ras to JUTA PHARMA GMBH?
Verified from 141 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| USV PRIVATE LIMITED | $3.6M | 141 | 100.0% |
JUTA PHARMA GMBH sources Ras from 1 verified Indian supplier based on 141 customs records. The primary supplier is USV PRIVATE LIMITED accounting for 100.0% of imports.
How Does JUTA PHARMA GMBH Compare to Nearest Ras Importers?
Buyers ranked immediately above and below #7 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | FAWDON MAUFACTURING CENTRE (SF) | UNITED KINGDOM | $3.5M | 71 | $50.0K |
| 17 | ASCEND LABORATORIES LLC | UNITED STATES | $3.5M | 69 | $50.0K |
| 7 | JUTA PHARMA GMBH ★ | GERMANY | $2.8M | 55 | $50.0K |
| 15 | FAWDON MANUFACTURING CENTRE ( SF ) | UNITED KINGDOM | $2.5M | 50 | $50.0K |
| 8 | DR. REDDYS LABORATORIES, INC | UNITED STATES | $1.8M | 35 | $50.0K |
JUTA PHARMA GMBH ranks #7 among 2,323 Ras importers from India. Average shipment value of $50.0K compared to the market average of $13.6K. The closest competitors by value are FAWDON MAUFACTURING CENTRE (SF) and ASCEND LABORATORIES LLC.
Where Does JUTA PHARMA GMBH Import Ras To?
Destination countries from 141 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| GERMANY | $3.6M | 141 | 100.0% |
JUTA PHARMA GMBH imports Ras to 1 country. The primary destination is GERMANY receiving 100.0% of shipments worth $3.6M.
What Ras Formulations Does JUTA PHARMA GMBH Import?
| Formulation | Value | Shipments |
|---|---|---|
| GRASUSTEK INJ 6MG/0.6ML PFS EU HR-RO BAT | $158.9K | 5 |
| GRASUSTEK INJ 6MG/0.6ML PFS FR ZENTIVA B | $158.5K | 5 |
| GRASUSTEK INJ 6MG/0.6ML PFS EU AT-DE BAT | $158.4K | 4 |
| GRASUSTEK INJ 6MG/0.6ML PFS EU HU-IS BAT | $102.8K | 3 |
| GRASUSTEK INJ 6MG/0.6ML PFS CZ/SK BATCH | $100.0K | 2 |
| GRASUSTEK INJ 6MG 0.6ML PFS EU HR RO BATCH NO 35000524 MFG FEB 2025 EXP JAN 2028 | $71.5K | 3 |
| GRASUSTEK INJ 6MG 0 6ML PFS FR ZENTIVA BATCH NO 35000540 MFG APR 2025 EXP MAR 2028 | $63.6K | 2 |
| GRASUSTEK INJ 6MG 0 6ML PFS FR ZENTIVA BATCH NO 35000322 MFG MAR 2023 EXP FEB 2026 | $61.7K | 2 |
| GRASUSTEK INJ 6MG 0 6ML PFS EU HR RO BATCH NO 35000321 MFG FEB 2023 EXP JAN 2026 | $60.7K | 2 |
| GRASUSTEK INJ 6MG 0 6ML PFS EU HR RO BAT | $60.7K | 2 |
JUTA PHARMA GMBH imports 97 distinct Ras formulations from India. The top formulation is GRASUSTEK INJ 6MG/0.6ML PFS EU HR-RO BAT with 5 shipments worth $158.9K.
Regulatory Requirements: Importing Ras into Germany
What JUTA PHARMA GMBH and other importers must comply with to import Ras from India
Regulatory Authority
Federal Institute for Drugs and Medical Devices (BfArM) / European Medicines Agency (EMA) (BfArM/EMA)
Approval Process for Generic Ras
Marketing Authorisation Application (MAA) under EU Directive 2001/83/EC. Decentralized or Mutual Recognition Procedure for generics. Requires CTD Module 1–5 dossier.
Typical timeline: 12–18 months via Decentralized Procedure
GMP Requirements
EU GMP (EudraLex Vol. 4) compliance; GMP certificate issued by competent authority; WHO Prequalification accepted as supporting evidence
Import Licence & Documentation
Wholesale Distribution Authorisation (WDA) and Manufacturing/Import Authorisation (MIA) required for importer. Qualified Person (QP) must certify each batch.
Labeling & Packaging
EU labeling per Directive 2001/83/EC; German language patient leaflet (PIL) mandatory; serialization under EU Falsified Medicines Directive (FMD)
Note: EU FMD serialization and tamper-evident packaging mandatory since February 2019. Indian API/FDF manufacturers must hold EU GMP certificate.
Regulatory information is provided for general reference based on publicly available BfArM/EMA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with BfArM/EMA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Ras from India and How Much Does JUTA PHARMA GMBH Import?
India exported $31.5M worth of Ras through 15,000 shipments from 1156 suppliers to 176 countries, serving 2,323 buyers globally. JUTA PHARMA GMBH imports $3.6M of this total, accounting for 2.3% of India's Ras exports with 141 shipments from GERMANY. This is verified from 141 customs shipment records covering 97 distinct formulations.
What Is the Average Order Value for JUTA PHARMA GMBH's Ras Imports?
JUTA PHARMA GMBH's average Ras order value is $25.9K per consignment, based on 141 shipments totaling $3.6M. JUTA PHARMA GMBH is based in GERMANY and ranks #7 among all Ras importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Ras to JUTA PHARMA GMBH?
JUTA PHARMA GMBH sources Ras from 1 verified Indian supplier: USV PRIVATE LIMITED ($3.6M, 100.0%). This is based on 141 customs records.
How Does JUTA PHARMA GMBH Compare to Other Ras Importers?
JUTA PHARMA GMBH ranks #7 among 2,323 Ras importers from India with a 2.3% market share. The top 3 importers are MYLAN IRELAND LIMITED ($5.4M), MYLAN IRELAND LTD ($5.2M), FAWDON MAUFACTURING CENTRE (SF) ($3.5M). JUTA PHARMA GMBH processed 141 shipments from GERMANY.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ras — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ras shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: JUTA PHARMA GMBH matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as JUTA PHARMA GMBH's capped import value divided by total capped export value for Ras across all Indian exporters.
- 5.Verified Records: This page is backed by 141 individual customs records matching JUTA PHARMA GMBH importing Ras, covering 97 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 176+ countries, 2,323+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ras Import Data for JUTA PHARMA GMBH
Access order-level details, pricing data, supplier connections, and competitive analysis for JUTA PHARMA GMBH's Ras imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
JUTA PHARMA GMBH
Company Profile
Multiple products · $0 total trade · Multiple categories
JUTA PHARMA GMBH × Ras
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for JUTA PHARMA GMBH.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ras. For current order-level data, contact TransData Nexus.